Please use this identifier to cite or link to this item: https://dspace.ncfu.ru/handle/20.500.12258/26162
Title: Mild post-COVID syndrome in young patients
Other Titles: Течение постковидного синдрома легкой степени тяжести у молодых пациентов
Authors: Ivchenko, G. S.
Ивченко, Г. С.
Lobzhanidze, N. N.
Лобжанидзе, Н. Н.
Rusina, D. S.
Русина, Д. С.
Denisova, E. V.
Денисова, Е. В.
Ivchenko, A. A.
Ивченко, А. А.
Keywords: Hyperammonemia;Post-COVID syndrome;Cognitive disorders;Hepatic encephalopathy
Issue Date: 2023
Citation: Ivchenko, G.S., Lobzhanidze, N.N., Rusina, D.S., Denisova, E.V., Ivchenko, A.A. Mild post-COVID syndrome in young patients // Terapevticheskii Arkhiv. - 2023. - 95 (8). - pp. 674-678. - DOI: 10.26442/00403660.2023.08.202349
Series/Report no.: Terapevticheskii Arkhiv
Abstract: Many COVID-19 survivors suffer from post-COVID syndrome, which significantly worsens the quality of life. Its presentation is quite diverse, with cognitive disorders being of particular importance. Liver injury due to the direct virus action and the treatment of the new coronavirus infection can persist for a long time during the recovery period and lead to hyperammonemia, which can cause cognitive disorders, including minimal hepatic encephalopathy. Aim. To study cognitive disorders in post-COVID syndrome and the possibility of their treatment with L-ornithine-L-aspartate. Materials and methods. The study included 30 students from 18 to 24 years old who had COVID-19 and decreased attention, memory impairment, and other cognitive disorders inherent in hepatic encephalopathy of latent (grade 0) or mild (grade 1) severity, without pronounced impairment of intelligence, memory, speech, and learning ability. Hyperammonemia, elevated alanine aminotransferase, aspartate aminotransferase, and γ-glutamyl transpeptidase, signs of hepatic encephalopathy according to psychometric tests, were reported in young people. All patients in the study were treated with L-ornithine-L-aspartate to correct the ammonia blood level and improve signs of hepatic encephalopathy and the general condition. Results and conclusion. An improvement in the objective findings, liver enzymes, a decrease in ammonia level, and an improvement in testing results for changes in cognitive functions were reported.
URI: http://hdl.handle.net/20.500.12258/26162
Appears in Collections:Статьи, проиндексированные в SCOPUS, WOS

Files in This Item:
File Description SizeFormat 
scopusresults 2861 .pdf
  Restricted Access
137.23 kBAdobe PDFView/Open
WoS 1753 .pdf
  Restricted Access
121.64 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.